“…Alternatively, if the glycan is glucosylated or if it was first trimmed by ERManI or EDEM2 (which have higher specificity for Man B), ManIA could remove Man C, which would allow binding to OS-9 and targeting to ERAD. However, this would require dissociation from CNX, and removal of Man C strongly decreases sensitivity to glucosidase II [1,30,31], which would prevent the glycoprotein from being deglucosylated and leaving the CNX cycle. Altogether, ManIA would tend to prolong the permanence in the CNX folding cycle of a glycoprotein molecule that is preferentially glucosylated (a good substrate of UDP-Glc:glycoprotein glucosyltransferase) and remove one that is not glucosylated, targeting it to ERAD.…”